je.st
news
BRILINTA Receives US FDA Approval For New Administration Option
2015-04-01 08:02:52| drugdiscoveryonline Home Page
AstraZeneca recently announced that the US Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow BRILINTA 90 mg tablets whole
Tags: option
administration
approval
receives
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||